Alcon Inc. Ordinary Shares

ALCNYSEUSD
63.64 USD
0.36 (0.56%)AT CLOSE (11:59 AM EDT)
63.59
0.05 (0.08%)
POST MARKET (AS OF 07:15 PM EDT)
Post Market
AS OF 07:15 PM EDT
63.59
0.05 (0.08%)
🔴Market: CLOSED
Open?$64.53
High?$64.98
Low?$63.60
Prev. Close?$64.00
Volume?2.1M
Avg. Volume?2.0M
VWAP?$64.04
Rel. Volume?1.09x
Bid / Ask
Bid?$61.41 × 100
Ask?$65.25 × 100
Spread?$3.84
Midpoint?$63.33
Valuation & Ratios
Market Cap?31.0B
Shares Out?N/A
P/E Ratio?70.54
P/B Ratio?1.59
EPS?$0.90
Dividend?0.00%
Ex-Dividend?N/A
News
Profile
Alcon is one of the leading visioncare companies in the world. Following nine years as a Novartis subsidiary, it was spun off as a public company in April 2019. Alcon operates in two segments: visioncare and surgical. Visioncare comprises contact lenses, lenscare solutions, and a suite of ocular health products. With brands like Dailies, Total1, and Air Optix, Alcon controls about one fourth of the US contact lens market. Surgical comprises intraocular lenses, ophthalmic surgical equipment, and consumables used during surgeries. Its main products include Centurion, a phacoemulsification device used during cataract surgeries, and a portfolio of IOLs including PanOptix and Vivity. Alcon has one of the largest installed bases of eye surgical equipment in the world.
Employees
25.9K
Market Cap
31.0B
Industry
N/A
Listed
2019-04-09
Technical Outlook
Loading...
Fundamental Outlook
Loading...
Short Interest
Loading...
Financial Health
Current Ratio?2.16Strong
Quick Ratio?1.31Adequate
Cash Ratio?0.44Low
Debt/Equity?0.20Low
ValuationFAIRLY VALUED
Score
60/100
P/E?
70.5PRICEY
P/B?
1.59CHEAP
P/S?
3.62FAIR
P/FCF?
N/A
EV/EBITDA?
31.9HIGH
EV/Sales?
3.96FAIR
Returns & Efficiency
ROE?
2.3%WEAK
ROA?
1.6%WEAK
Cash Flow & Enterprise
FCF?N/A
Enterprise Value?$34.0B
Fundamentals ratios updated end of day